Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127613761 | 12761376 | 1 | I | 20160824 | 20160914 | 20160920 | 20160920 | EXP | CA-ASTRAZENECA-2016SE97931 | ASTRAZENECA | 27739.00 | DY | M | Y | 0.00000 | 20160920 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127613761 | 12761376 | 1 | PS | ZOLADEX LA | GOSERELIN ACETATE | 1 | Subcutaneous | U | 20578 | 10.8 | MG | IMPLANT | |||||||
| 127613761 | 12761376 | 2 | SS | ZOLADEX LA | GOSERELIN ACETATE | 1 | Subcutaneous | U | 20578 | 10.8 | MG | IMPLANT |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127613761 | 12761376 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127613761 | 12761376 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127613761 | 12761376 | 1 | 20100522 | 0 | ||
| 127613761 | 12761376 | 2 | 20100525 | 0 |